These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 32014090

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Questions swirl around failures of disease-modifying Huntington's drugs.
    Sheridan C.
    Nat Biotechnol; 2021 Jun; 39(6):650-652. PubMed ID: 34113039
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Study of cholesterol metabolism in Huntington's disease.
    Leoni V, Caccia C.
    Biochem Biophys Res Commun; 2014 Apr 11; 446(3):697-701. PubMed ID: 24525128
    [Abstract] [Full Text] [Related]

  • 11. Investigational agents for the management of Huntington's disease.
    Müller T.
    Expert Opin Investig Drugs; 2017 Feb 11; 26(2):175-185. PubMed ID: 27927041
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Paroxetine retards disease onset and progression in Huntingtin mutant mice.
    Duan W, Guo Z, Jiang H, Ladenheim B, Xu X, Cadet JL, Mattson MP.
    Ann Neurol; 2004 Apr 11; 55(4):590-4. PubMed ID: 15048901
    [Abstract] [Full Text] [Related]

  • 15. Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor.
    Eddings CR, Arbez N, Akimov S, Geva M, Hayden MR, Ross CA.
    Neurobiol Dis; 2019 Sep 11; 129():118-129. PubMed ID: 31108174
    [Abstract] [Full Text] [Related]

  • 16. Curcumin-Loaded Nanoparticles Based on Amphiphilic Hyaluronan-Conjugate Explored as Targeting Delivery System for Neurodegenerative Disorders.
    Pepe G, Calce E, Verdoliva V, Saviano M, Maglione V, Di Pardo A, De Luca S.
    Int J Mol Sci; 2020 Nov 23; 21(22):. PubMed ID: 33238365
    [Abstract] [Full Text] [Related]

  • 17. Fibroblast growth factor 9 activates anti-oxidative functions of Nrf2 through ERK signalling in striatal cell models of Huntington's disease.
    Yusuf IO, Chen HM, Cheng PH, Chang CY, Tsai SJ, Chuang JI, Wu CC, Huang BM, Sun HS, Yang SH.
    Free Radic Biol Med; 2019 Jan 23; 130():256-266. PubMed ID: 30391672
    [Abstract] [Full Text] [Related]

  • 18. Dysregulated Brain Cholesterol Metabolism Is Linked to Neuroinflammation in Huntington's Disease.
    González-Guevara E, Cárdenas G, Pérez-Severiano F, Martínez-Lazcano JC.
    Mov Disord; 2020 Jul 23; 35(7):1113-1127. PubMed ID: 32410324
    [Abstract] [Full Text] [Related]

  • 19. The impairment of cholesterol metabolism in Huntington disease.
    Leoni V, Caccia C.
    Biochim Biophys Acta; 2015 Aug 23; 1851(8):1095-105. PubMed ID: 25596342
    [Abstract] [Full Text] [Related]

  • 20. Huntington's Disease: The Most Curable Incurable Brain Disorder?
    Wild EJ.
    EBioMedicine; 2016 Jun 23; 8():3-4. PubMed ID: 27428401
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.